drugset / Trial / NCT04739293
Study of ON 123300 in Patients With Advanced Cancer
NaSequentialOpen-labelTreatment
Summary
This study will investigate the safety of the drug ON 123300 at increasing doses to determine the best dose to use in future clinical trials.
Timeline
- Start
- 2021-05-13
- Primary completion
- 2024-10
- Completion
- 2024-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Narazaciclib | Small molecule | 40 mg | Oral |
| Subject | Narazaciclib | Small molecule | 80 mg | Oral |
| Subject | Narazaciclib | Small molecule | 120 mg | Oral |
Indications
No indication recorded.